• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断的急性早幼粒细胞白血病患者早期死亡的影响因素

The Factors Affecting Early Death in Newly Diagnosed APL Patients.

作者信息

Ciftciler Rafiye, Haznedaroglu Ibrahim Celalettin, Aksu Salih, Ozcebe Osman, Sayınalp Nilgun, Malkan Umit Yavuz, Buyukasık Yahya

机构信息

Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey.

Dıskapı Education and Research Hospital, Department of Hematology, Ankara, Turkey.

出版信息

Open Med (Wars). 2019 Sep 12;14:647-652. doi: 10.1515/med-2019-0074. eCollection 2019.

DOI:10.1515/med-2019-0074
PMID:31565673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6744608/
Abstract

BACKGROUND AND AIM

In the past, acute promyelocytic leukemia (APL) was considered as one of the most rapidly lethal form of acute myeloid leukemia (AML). The objective of this study was to assess clinical parameters affecting early death (ED) in patients with APL.

MATERIALS AND METHODS

Forty-three patients with APL who were diagnosed at Hacettepe University Hospital between the years of 2005 and 2018 were evaluated.

RESULTS

In univariate analyses, presentation with hemorrhage, DIC or infection at diagnosis, ECOG performance score, blast percentage on bone marrow, Sanz score, leukocyte, thrombocyte, fibrinogen and LDH levels were found to be statistically significantly different between patients with ER and patients without ED. In multivariate analysis, presentation with hemorrhage, DIC or infection at diagnosis, ECOG performance score, blast percentage on bone marrow, Sanz score, leukocyte, thrombocyte, fibrinogen, and LDH levels were found to be independent factors that are related with higher rate of ED in 30 days after treatment.

CONCLUSION

Induction chemotherapy should be started as soon as possible after diagnosis of APL. Improving ED rates may become the greatest challenge for the future treatment of the diseases.

摘要

背景与目的

过去,急性早幼粒细胞白血病(APL)被认为是急性髓系白血病(AML)中致死速度最快的类型之一。本研究的目的是评估影响APL患者早期死亡(ED)的临床参数。

材料与方法

对2005年至2018年间在哈杰泰佩大学医院确诊的43例APL患者进行了评估。

结果

在单因素分析中,发现确诊时伴有出血、弥散性血管内凝血(DIC)或感染、东部肿瘤协作组(ECOG)体能状态评分、骨髓原始细胞百分比、桑兹评分、白细胞、血小板、纤维蛋白原和乳酸脱氢酶(LDH)水平在早期死亡患者和无早期死亡患者之间存在统计学显著差异。在多因素分析中,确诊时伴有出血、DIC或感染、ECOG体能状态评分、骨髓原始细胞百分比、桑兹评分及白细胞、血小板、纤维蛋白原和LDH水平被发现是与治疗后30天内较高早期死亡率相关的独立因素。

结论

APL确诊后应尽快开始诱导化疗。提高早期死亡率可能成为未来该疾病治疗的最大挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/343f/6744608/9b9304d8235c/med-14-647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/343f/6744608/fe9debfa3396/med-14-647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/343f/6744608/9b9304d8235c/med-14-647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/343f/6744608/fe9debfa3396/med-14-647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/343f/6744608/9b9304d8235c/med-14-647-g002.jpg

相似文献

1
The Factors Affecting Early Death in Newly Diagnosed APL Patients.新诊断的急性早幼粒细胞白血病患者早期死亡的影响因素
Open Med (Wars). 2019 Sep 12;14:647-652. doi: 10.1515/med-2019-0074. eCollection 2019.
2
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.急性早幼粒细胞白血病患者早期死亡相关风险因素的评估:一项回顾性研究。
Ann Hematol. 2022 May;101(5):1049-1057. doi: 10.1007/s00277-022-04798-8. Epub 2022 Feb 21.
3
Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.细胞因子对初诊急性早幼粒细胞白血病患者早期死亡和凝血障碍的影响。
Front Immunol. 2023 Mar 31;14:1100151. doi: 10.3389/fimmu.2023.1100151. eCollection 2023.
4
Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.急性早幼粒细胞白血病与其他伴有弥散性血管内凝血的急性髓系白血病亚型之间实验室特征的比较。
Blood Res. 2013 Dec;48(4):250-3. doi: 10.5045/br.2013.48.4.250. Epub 2013 Dec 24.
5
[Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].[全反式维甲酸对新诊断急性早幼粒细胞白血病的疗效:我们的经验]
Srp Arh Celok Lek. 1995 Nov-Dec;123(11-12):279-85.
6
Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.未经选择的急性早幼粒细胞白血病患者的真实生活结局:一项单中心14年的经验。
Rom J Intern Med. 2020 Sep 1;58(3):138-145. doi: 10.2478/rjim-2020-0011.
7
Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.急性早幼粒细胞白血病合并弥散性血管内凝血患者的重组人血栓调节蛋白治疗:一项开放标签、多中心、上市后监测研究队列的回顾性分析
Thromb Res. 2014 May;133(5):772-81. doi: 10.1016/j.thromres.2014.02.025. Epub 2014 Mar 4.
8
[Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].[初诊急性早幼粒细胞白血病合并弥散性血管内凝血的经验性治疗分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):315-22. doi: 10.7534/j.issn.1009-2137.2014.02.010.
9
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.接受全反式维甲酸(ATRA)和化疗治疗的t(15;17)阳性急性早幼粒细胞白血病儿童及青少年血栓出血性早期死亡的预测因素
Ann Hematol. 2017 Sep;96(9):1449-1456. doi: 10.1007/s00277-017-3042-6. Epub 2017 Jun 8.
10
Management of Disseminated Intravascular Coagulation in Acute Leukemias.急性白血病弥漫性血管内凝血的处理。
Hamostaseologie. 2021 Apr;41(2):120-126. doi: 10.1055/a-1393-8302. Epub 2021 Apr 15.

引用本文的文献

1
Analysis of early and treatment related deaths among children and adolescents with acute myeloid leukemia in Poland: 2005-2023.波兰儿童和青少年急性髓系白血病早期及治疗相关死亡分析:2005 - 2023年
Front Pediatr. 2024 Oct 17;12:1482720. doi: 10.3389/fped.2024.1482720. eCollection 2024.
2
Analysis of early death in critically ill patients with acute promyelocytic leukaemia in the HICU.危重病患者中急性早幼粒细胞白血病早期死亡的分析。
Sci Rep. 2024 Aug 28;14(1):19987. doi: 10.1038/s41598-024-71082-2.
3
Clinical characteristics and analysis of related factors associated with early death in newly diagnosed patients with acute promyelocytic leukemia.

本文引用的文献

1
Addressing the room for improvement in management of acute promyelocytic leukemia.探讨急性早幼粒细胞白血病管理的改进空间。
Eur J Haematol. 2019 Jun;102(6):479-485. doi: 10.1111/ejh.13229. Epub 2019 Apr 7.
2
[Relationship between Peripheral Blood White Blood Cell Count and Early Death Rate in Patients with Acute Promyelocytic Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Jun;25(3):718-722. doi: 10.7534/j.issn.1009-2137.2017.03.015.
3
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.全反式维甲酸时代急性早幼粒细胞白血病诱导治疗期间致命性出血的决定因素。
初诊急性早幼粒细胞白血病患者早期死亡的临床特征及相关因素分析
Discov Oncol. 2024 Aug 27;15(1):375. doi: 10.1007/s12672-024-01241-4.
4
Acute promyelocytic leukemia with additional chromosome abnormalities in a patient positive for HIV: A case report and literature review.一名HIV阳性患者伴有额外染色体异常的急性早幼粒细胞白血病:病例报告及文献综述
Oncol Lett. 2024 Apr 19;27(6):274. doi: 10.3892/ol.2024.14407. eCollection 2024 Jun.
5
Causes and risk factors for early death in adult patients with acute promyelocytic leukemia: a real-life experience.成人急性早幼粒细胞白血病患者早期死亡的原因及危险因素:一项真实病例经验
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S122-S128. doi: 10.1016/j.htct.2024.02.020. Epub 2024 Mar 21.
6
Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals.急性早幼粒细胞白血病患者的弥散性血管内凝血:美国医院结局与医疗负担的回顾性分析
Turk J Haematol. 2024 Mar 1;41(1):1-8. doi: 10.4274/tjh.galenos.2024.2023.0479. Epub 2024 Feb 20.
7
Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.细胞因子对初诊急性早幼粒细胞白血病患者早期死亡和凝血障碍的影响。
Front Immunol. 2023 Mar 31;14:1100151. doi: 10.3389/fimmu.2023.1100151. eCollection 2023.
8
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.外周血白细胞计数和肿瘤坏死因子-α对急性早幼粒细胞白血病早期死亡的影响。
BMC Cancer. 2023 Jan 7;23(1):27. doi: 10.1186/s12885-022-10499-2.
9
Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China.替加环素相关低纤维蛋白原血症的发生率、特征及危险因素:一项中国多中心回顾性研究
Front Pharmacol. 2022 Oct 11;13:943674. doi: 10.3389/fphar.2022.943674. eCollection 2022.
10
Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia.新诊断的低中危急性早幼粒细胞白血病患者早期死亡的预测因素及临床特征
Front Oncol. 2022 Sep 14;12:895777. doi: 10.3389/fonc.2022.895777. eCollection 2022.
Blood. 2017 Mar 30;129(13):1763-1767. doi: 10.1182/blood-2016-10-747170. Epub 2017 Jan 12.
4
[Clinical features and prognostic analysis of high-risk acute promyelocytic leukemia patients].[高危急性早幼粒细胞白血病患者的临床特征及预后分析]
Zhonghua Xue Ye Xue Za Zhi. 2016 May 14;37(5):360-5. doi: 10.3760/cma.j.issn.0253-2727.2016.05.002.
5
The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects.乳酸脱氢酶作为肿瘤标志物的实际作用:生化与临床方面
Adv Exp Med Biol. 2015;867:115-24. doi: 10.1007/978-94-017-7215-0_8.
6
The unique hemostatic dysfunction in acute promyelocytic leukemia.急性早幼粒细胞白血病中独特的止血功能障碍。
Semin Thromb Hemost. 2014 Apr;40(3):332-6. doi: 10.1055/s-0034-1370792. Epub 2014 Mar 3.
7
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.尽管采用全反式维甲酸治疗,但急性早幼粒细胞白血病的早期死亡率仍然很高。
Blood. 2011 Aug 4;118(5):1248-54. doi: 10.1182/blood-2011-04-346437. Epub 2011 Jun 8.
8
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.急性早幼粒细胞白血病的持续高早期死亡率:来自瑞典成人急性白血病登记处的一项基于人群的报告。
Leukemia. 2011 Jul;25(7):1128-34. doi: 10.1038/leu.2011.78. Epub 2011 Apr 19.
9
All trans retinoic acid and cancer.全反式维甲酸与癌症。
Immunopharmacol Immunotoxicol. 2011 Jun;33(2):241-9. doi: 10.3109/08923973.2010.521507. Epub 2010 Oct 8.
10
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.基于全反式维甲酸和蒽环类药物联合阿糖胞苷巩固治疗高危患者的急性早幼粒细胞白血病的风险适应性治疗:治疗结果的进一步改善。
Blood. 2010 Jun 24;115(25):5137-46. doi: 10.1182/blood-2010-01-266007. Epub 2010 Apr 14.